Content of review 1, reviewed on March 27, 2017

This manuscript (VIRU781) reports the construction of efficient HCV-polyepitope vaccine candidates harbouring immune-enhancer sequences (H-2Dd (E2405-414: E2) and HLA-A*0201 (E1363-372: E1 and Core35-44: C) restricted CD8+ T-cell epitopes of HCV). Moreover, the authors evaluate their immunogenicity in BALB/c mice.

Comments:

Several typing errors, as well as other mistakes should be amended:

(1) Title: "harboring" should be replaced by "harbouring"

(2) Abstract: Page 1, line 35: "sequesnce" should be replaced by "sequence"

(3) Page 6, line 1: "oligoes" should be replaced by "oligos"

(4) The authors sometimes use polytope and polyepitope. Please, they should always use the same word in the manuscript.

(5) Page 10, line 1: "polyepitoe" should be replaced by "polyepitope"

(6) Page 14, line 37: "polyepitop" should be replaced by "polyepitope"

(7) Page 16, line 45: "exploited" should be replaced by "used"

(8) There are too many references (45).

(9) English expression needs to be improved.

Source

    © 2017 the Reviewer (CC BY 4.0).

References

    Arash, A., Farzin, R., Arash, M., Reza, A. M., Sima, R. 2010. Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice. Virus Genes.